Browse diseases

…afety and durability of telitacicept treatment in patients with SLE by identifying the reasons for treatment discontinuation and po…

… was attributed to the combined prothrombotic effects of active SLE inflammation, proteinuria and marked hypoalbuminaemia. Treatmen…

…AC-positive patients (5.2 WP).Autoimmune disease, predominantly SLE, was present in 71% of LAC-negative and 68% of LAC-positive pat…

…amework is constructed to optimize the classification model for systemic lupus erythematosus (SLE) brain function abnormalities by integrating co-spatial mo…

…clinical and serological predictors present at the diagnosis of systemic lupus erythematosus (SLE) associated with mortality, and to describe the distributi…

…00M doseConclusions In these preliminary findings of obe-cel in srSLE, obe-cel demonstrated a favourable safety profile and clinical …

…Objectives While thrombosis is a hallmark of antiphospholipid syndrome (APS), recurrent or refractory thrombotic events raise concern …

…ease (MCTD), undifferentiated connective tissue disease (UCTD), rheumatoid arthritis (RA), primary anti-phospholipid syndrome (PAPS)), and 22 health…

…onferred an increased risk for CV events in this Latin-American lupus population. Patients with renal lupus were at higher risk. No a…

…ere pulmonary hypertension (PH) as the initial manifestation of systemic lupus erythematosus (SLE).Methods Case report A 21-year-old woman, with a family hi…

…clinical factors associated with atherosclerosis progression in Systemic Lupus Erythematosus (SLE)Methods Sixty-nine patients with SLE underwent ultrasound …

…ctives Acute lupus pneumonitis (ALP) is a rare manifestation of Systemic Lupus Erythematous (SLE). We report a case of recurrent ALP treated with anifrolum…